Upgrade to SI Premium - Free Trial

Novavax (NVAX) PT Raised to $9 at TD Cowen

May 6, 2026 8:20 AM
TD Cowen analyst Chris LoBianco raised the price target on Novavax (NASDAQ: NVAX) to $9.00 (from $8.00) while maintaining a Hold rating.

Categories

Analyst PT Change